These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 9119161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mammalian cells and their contaminants.
    Minor PD.
    Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Strategy for adventitious agent assays.
    Robertson JS.
    Dev Biol Stand; 1996; 88():37-40. PubMed ID: 9119160
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insect cells as a new substrate for vaccine production.
    Dalemans W.
    Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
    [Abstract] [Full Text] [Related]

  • 10. Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
    Murata H, Macauley J, Lewis AM, Peden K.
    Vaccine; 2011 Apr 12; 29(17):3155-61. PubMed ID: 21354480
    [Abstract] [Full Text] [Related]

  • 11. Molecular methods for virus discovery.
    Jarrett RF, Johnson D, Wilson KS, Gallagher A.
    Dev Biol (Basel); 2006 Apr 12; 123():77-88; discussion 119-32. PubMed ID: 16566437
    [Abstract] [Full Text] [Related]

  • 12. Current issues in viral assays and viral clearance evaluation.
    Lubiniecki AS.
    Dev Biol Stand; 1996 Apr 12; 88():9-11. PubMed ID: 9119167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C, Motitschke A.
    Biologicals; 2010 May 12; 38(3):362-5. PubMed ID: 20335053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Laboratory host systems for extraneous agent testing in avian live virus vaccines: problems encountered.
    Philipp HC, Kolla I.
    Biologicals; 2010 May 12; 38(3):350-1. PubMed ID: 20335050
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the sensitivity of in vitro and in vivo tests for detection of the presence of a bovine viral diarrhoea virus type 1 strain.
    Antonis AF, Bouma A, de Bree J, de Jong MC.
    Vet Microbiol; 2004 Sep 08; 102(3-4):131-40. PubMed ID: 15327789
    [Abstract] [Full Text] [Related]

  • 19. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
    Petricciani JC, Milstien JB.
    Dev Biol Stand; 2004 Sep 08; 37():229-34. PubMed ID: 73485
    [Abstract] [Full Text] [Related]

  • 20. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP.
    Dev Biol (Basel); 2006 Sep 08; 126():309-19; discussion 327. PubMed ID: 17058507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.